Psychotropic medication management for youth in state care: Consent, oversight, and policy considerations

Child Welfare

Volumn 86, Issue 5, 2007, Pages 175-192

  Naylor, Michael W ^a,b   Davidson, Christine V ^a,b   Ortega Piron, D Jean ^c   Bass, Arin ^b   Gutierrez, Alice ^b   Hall, Angela ^b  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Illinois Department of Children and Family Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; CASE MANAGEMENT; CHILD; CHILD WELFARE; CUSTODY; DRUG APPROVAL; EMOTIONAL DISORDER; EXPERT WITNESS; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; LEGAL ASPECT; PATIENT REFERRAL; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT; UNITED STATES;

ADOLESCENT; AFFECTIVE SYMPTOMS; CASE MANAGEMENT; CHILD; CHILD BEHAVIOR DISORDERS; CHILD CUSTODY; CHILD WELFARE; DRUG APPROVAL; EXPERT TESTIMONY; HEALTH POLICY; HUMANS; INFORMED CONSENT; PSYCHOTROPIC DRUGS; REFERRAL AND CONSULTATION; STRESS DISORDERS, POST-TRAUMATIC; THIRD-PARTY CONSENT; UNITED STATES;

EID: 45549088617     PISSN: 00094021     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aman, M. G., Binder, C., & Turgay, A. (2004). Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behaviors, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology, 14, 243-254.
2. American Academy of Child and Adolescent Psychiatry. (2005). Oversight of psychotropic medication use for children in state custody: A best principles guideline. Available online at www.aacap.org/galleries/Practicelnformation/ FosterCare-BestPrinciples-FINAL.pdf.
3. Anderson, T. R., Naylor, M. W., Kruesi, M., & Stoewe, J. (2002). Co-pharmacy and poly-pharmacy in children and adolescents in substitute care. 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 2002. San Francisco, CA; Abstract # C-31.
4. Associated Press (2006). Parents charged with daughter's ADHD drug overdose death. Available online at www.foxnews.com/story/0, 2933, 250482, 00.html.
5. Bhatara, V., Feil, M., Hoagwood, K., Vitiello, B., & Zima, B. (2004). National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge. Journal of Attention Disorders, 7, 217-226.
6. Blumer, J. L. (1999). Off-label uses of drugs in children. Pediatrics, 104, 598-602.
7. Breland-Noble, A. M., Elbogen, E. B., Farmer, E. M., Dubs, M. S., Wagner, H. R., & Burns, B. J. (2004). Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatric Services, 55, 706-708.
8. Burns, B. J., Phillips, S. D., Wagner, H. R., Barth, R. P., Kolko, D. J., Campbell, Y., & Landsverk, J. (2004). Mental health need and access to mental health services by youths involved with child welfare: A national survey. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 960-970.
9. Correll, C. U., Leucht, S., & Kane, J. M. (2004). Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of one-year studies. American Journal of Psychiatry, 161, 414-425.
10. Delbello, M. P., Schwiers, M. L., Rosenberg, H. L., & Strakowski, S. M. (2002). A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1216-1223.
11. dos Reis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Health, 91, 1094-1099.
12. Halfon, N., Berkowitz, G., & Klee, L. (1992). Mental health service utilization by children in foster care in California. Pediatrics, 89, 1238-1244.
13. Harman, J. S., Childs, G. E., & Kelleher, K. J. (2000). Mental health utilization and expenditures by children in foster care. Archives of Pediatrics and Adolescent Medicine, 154, 1114-1117.
14. Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U. S. children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557-565.
15. Mclntyre, A., & Keesler, T. Y. (1986). Psychological disorders among foster children. Journal of Clinical Child Psychology, 15, 297-303.
16. Mellman, T. A., Miller, A. L., Weissman, E. M., Crismon, M. L., Essock, S. M., & Marder, S. R. (2001). Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms. Psychiatric Services, 52, 619-625.
17. Naylor, M. W., Anderson, T. R., & Morris, A. (2003). Child psychiatry and child welfare: A collaboration for change. Residential Treatment for Children and Youth, 21, 33-50.
18. Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514-521. (Pubitemid 38338129)
19. Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63, 679-685.
20. Pavuluri, M. N., Henry, D. B., Carbray, J. A., Sampson, G. A., Naylor, M. W., & Janicak, P. G. (2006). A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 16, 336-50.
21. Phelan, K. M. (2005). One year post-pediatric exclusivity postmarketing adverse event review, PID#D040058 (memorandum). Center for Drug Evaluation and Research. Available online at http://www.fda.gov/ohrms/dockets/ac/05/briefing/ 20054152b2-01-01-01-Concerta%20AE.pdf.
22. Physician's Desk Reference, 60th edition. (2006). Montvale, NJ: Thomson Healthcare.
23. Raghavan, R., Zima, B. T., Anderson, R. M., Leibowitz, A. A., Schuster, M. A., & Landsverk, J. (2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15, 97-106.
24. Safer, D. J., Zito, J. M., & dos Reis, S. (2003). Concomitant psychotropic medication for youth. American Journal of Psychiatry, 160, 438-449.
25. Stigler, K. A., Potenza, M. N., Posey, D. J., & McDougle, C. J. (2004). Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Pediatric Drugs, 6, 33-44.
26. Trupin, E. W., Tarico, VS., Low, B. P., Jemelka, R., & McClellan, J. (1993). Children on child protective service caseloads: prevalence and nature of serious emotional disturbance. Child Abuse & Neglect, 17, 345-355.
27. US Department of Health and Human Services. (1998). Code of Federal Regulations, Title 45, Chapter XIII, Part 1356, Section 60.
28. US Department of Health and Human Services. (2001). Code of Federal Regulations, Title 21, Part 50, Section 56.
29. US Department of Health and Human Services. (2003). Code of Federal Regulations, Title 45, Part 46, Subpart D, 401, Section 409.
30. U. S. Food and Drug Administration. (2004). FDA public health advisory: Suicidality in children and adolescents being treated with antidepressant medications. Available online at www.fda.gov/cder/drug/antidepressants/ SSRIPHA200410.htm.
31. Zima, B. T., Bussing, R., Crecelius, G. M., Kaufman, A., & Belin, T. R. (1999). Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. American Journal of Public Health, 89, 1732-1735.
32. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics & Adolescent Medicine, 157, 17-25.